Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 174081 - 174100 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01FX04) ipilimumab | YERVOY | 5MG/ML, 5MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01FX09) mogamulizumab | POTELIGEO | 4MG/ML, 4MG/ML INF CNC SOL 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Sezary Syndrome; Mycosis Fungoides | KyowaKirinHoldingsB.V.,Hoofddorp |
| Czech Republic | (L01FX13) enfortumab vedotin | PADCEV | 20MG, 20MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | AstellasPharmaEuropeB.V.,Leiden |
| Czech Republic | (L01FX13) enfortumab vedotin | PADCEV | 30MG, 30MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | AstellasPharmaEuropeB.V.,Leiden |
| Czech Republic | (L01FX14) polatuzumab vedotin | POLIVY | 140MG, 140MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FX14) polatuzumab vedotin | POLIVY | 30MG, 30MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FY01) pertuzumab and trastuzumab | PHESGO | 1200MG/600MG, 1200MG/600MG INJ SOL 1X15ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FY01) pertuzumab and trastuzumab | PHESGO | 600MG/600MG, 600MG/600MG INJ SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATINA MYLAN | 5MG/ML, 5MG/ML INF PLV SOL 1X100MG , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | VIATRISLIMITED,Dublin |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATINA MYLAN | 5MG/ML, 5MG/ML INF PLV SOL 1X50MG , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | VIATRISLIMITED,Dublin |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN ACCORD | 5MG/ML, 5MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCAREPOLSKASp.zo.o.,Varšava |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN ACCORD | 5MG/ML, 5MG/ML INF CNC SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCAREPOLSKASp.zo.o.,Varšava |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN ACCORD | 5MG/ML, 5MG/ML INF CNC SOL 1X40ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCAREPOLSKASp.zo.o.,Varšava |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN KABI | 5MG/ML, 5MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | FreseniusKabis.r.o.,Praha |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN KABI | 5MG/ML, 5MG/ML INF CNC SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | FreseniusKabis.r.o.,Praha |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN TEVA | 5MG/ML, 5MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsCR,s.r.o.,Praha |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN TEVA | 5MG/ML, 5MG/ML INF CNC SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsCR,s.r.o.,Praha |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATINA MYLAN | 5MG/ML, 5MG/ML INF PLV SOL 1X100MG , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | VIATRISLIMITED,Dublin |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATINA MYLAN | 5MG/ML, 5MG/ML INF PLV SOL 1X50MG , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | VIATRISLIMITED,Dublin |
| Czech Republic | (L01XC02) rituximab | MABTHERA | 100MG, 100MG INF CNC SOL 2X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
Pages
